Vifor Pharma: UK regulator probes Vifor Pharma for anti-competitive behaviour
(marketscreener.com) Britain's antitrust regulator said on Wednesday it has launched an investigation into Swiss drugmaker Vifor Pharma for suspected anti-competitive conduct in the supply of its blockbuster iron deficiency medicine Ferinject.https://www.marketscreener.com/news/latest/UK-regulator-probes-Vifor-Pharma-for-anti-competitive-behaviour--45852882/?utm_medium=RSS&utm_content=20240131
Read full article »
Vifor Pharma is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases.
Read more